A drug for the treatment of bronchial asthma, as well as ALS and MS
In stock: 5 available
Product Details
Ketas (Ibudilast) 10 mg 500
capsules. Ketas (Ibudilast) is used for the treatment of bronchial asthma, and has also been clinically tested for the treatment of amyotrophic lateral sclerosis (ALS) and Multiple sclerosis, as a drug that slows down the progression of the disease.
Product Information
Ketas 10 mg. 500 capsules.
Active ingredient: Ibudilast
Manufacturer: KYORIN Pharmaceutical
Pharmacological action
Ibudilast is an anti—inflammatory and neuroprotective agent, acts as a phosphodiesterase inhibitor, suppressing the PDE4 subtype to the greatest extent, but also demonstrating significant inhibition of other PDE4 subtypes.
Indications
Treatment of Multiple sclerosis, ALS, asthma, cerebrovascular diseases.
Method of administration and dosage
Orally.
Description
Cerebrovascular disorders: this medicine improves cerebrovascular disorder and relieves the subjective symptom of dizziness.
It is usually used to treat dizziness in chronic cerebrovascular accident caused by the effects of a cerebral infarction.
Bronchial asthma: this medicine suppresses inflammation of the respiratory tract, reducing the hypersensitivity of the respiratory tract.
It is usually used to treat bronchial asthma.
Composition and form of release
Dosage form: capsules (white cap, white body).
Method of application
Your dosage schedule should be prescribed by a doctor or drawn up by a medical professional.